Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL976335 | 0.94 | TDP1 (0.37) | TDP1MEN1KMT2AGRM2 | |
| SCHEMBL976041 | 0.88 | TP53 (0.32) | TDP1MEN1KMT2A | |
| SCHEMBL976517 | 0.88 | TP53 (0.34) | TDP1MEN1KMT2AGRM2 | |
| SCHEMBL4987750 | 0.88 | — | — | |
| SCHEMBL975131 | 0.87 | TDP1 (0.34) | TDP1MEN1KMT2AGRM2 | |
| SCHEMBL975955 | 0.85 | TP53 (0.33) | TDP1MEN1KMT2AGRM2 | |
| SCHEMBL975818 | 0.85 | TP53 (0.33) | TDP1MEN1KMT2AGRM2 | |
| SCHEMBL12922168 | 0.85 | TP53 (0.35) | TDP1MEN1KMT2AGRM2 | |
| SCHEMBL974403 | 0.85 | TP53 (0.35) | TDP1MEN1KMT2AGRM2 | |
| SCHEMBL974729 | 0.85 | GRM2 (0.32) | MEN1KMT2AGRM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070173570-A1 | N-alkoxy-4, 4-dioxy-polyalkyl-piperidine compounds, with glycidyl or alkylcarbonyl groups as functional initiators for controlled radical polymerization | FUSO FRANCESCO | 2007-07-26 | — | — | US | claimed |
| EP-1341763-B1 | N-ALKOXY-4,4-DIOXY-POLYALKYL-PIPERIDINE COMPOUNDS, WITH GLYCIDYL OR ALKYLCARBONYL GROUPS AS FUNCTIONAL INITIATORS FOR CONTROLLED RADICAL POLYMERIZATION | CIBA SC HOLDING AG (CH) | 2004-06-16 | — | — | EP | claimed |
| US-20040049043-A1 | N-alkoxy-4,4-dioxy-polyalkyl-piperidine compounds, with glycidyl or alkylcarbonyl groups as functional initiators for controlled radical polymerization | CIBA SPECIALTY CHEMICALS CORP. | 2004-03-11 | — | — | US | claimed |
| EP-1341763-A2 | N-ALKOXY-4,4-DIOXY-POLYALKYL-PIPERIDINE COMPOUNDS, WITH GLYCIDYL OR ALKYLCARBONYL GROUPS AS FUNCTIONAL INITIATORS FOR CONTROLLED RADICAL POLYMERIZATION | Ciba SC Holding AG (CH) | 2003-09-10 | — | — | EP | claimed |
| WO-2002048109-A2 | N-ALKOXY-4,4-DIOXY-POLYALKYL-PIPERIDINES AS RADICAL POLYMERIZATION INITIATORS | CIBA SPECIALTY CHEMICLAS HOLDING INC. (CH) | 2002-06-20 | — | — | WO | claimed |
| US-7868171-B2 | N-alkoxy-4, 4-dioxy-polyalkyl-piperidines as radical polymerization initiators | CIBA SPECIALTY CHEMICALS CORP. (US) | 2011-01-11 | — | — | US | disclosed |
| US-7868171-B2 | N-alkoxy-4, 4-dioxy-polyalkyl-piperidines as radical polymerization initiators | CIBA SPECIALTY CHEMICALS CORP. (US) | 2011-01-11 | — | — | US | disclosed |
| US-7868171-B2 | N-alkoxy-4, 4-dioxy-polyalkyl-piperidines as radical polymerization initiators | CIBA SPECIALTY CHEMICALS CORP. (US) | 2011-01-11 | — | — | US | disclosed |
| US-20070173570-A1 | N-alkoxy-4, 4-dioxy-polyalkyl-piperidine compounds, with glycidyl or alkylcarbonyl groups as functional initiators for controlled radical polymerization | FUSO FRANCESCO | 2007-07-26 | — | — | US | disclosed |
| US-20070173570-A1 | N-alkoxy-4, 4-dioxy-polyalkyl-piperidine compounds, with glycidyl or alkylcarbonyl groups as functional initiators for controlled radical polymerization | FUSO FRANCESCO | 2007-07-26 | — | — | US | disclosed |
| US-20070173570-A1 | N-alkoxy-4, 4-dioxy-polyalkyl-piperidine compounds, with glycidyl or alkylcarbonyl groups as functional initiators for controlled radical polymerization | FUSO FRANCESCO | 2007-07-26 | — | — | US | disclosed |
| US-7235663-B2 | N-alkoxy-4,4-dioxy-polyalkyl-piperidines as radical polymerization inhibitors | CIBA SPECIALTY CHEMICALS CORP. (US) | 2007-06-26 | — | — | US | disclosed |
| US-7235663-B2 | N-alkoxy-4,4-dioxy-polyalkyl-piperidines as radical polymerization inhibitors | CIBA SPECIALTY CHEMICALS CORP. (US) | 2007-06-26 | — | — | US | disclosed |
| US-7235663-B2 | N-alkoxy-4,4-dioxy-polyalkyl-piperidines as radical polymerization inhibitors | CIBA SPECIALTY CHEMICALS CORP. (US) | 2007-06-26 | — | — | US | disclosed |
| EP-1341763-B1 | N-ALKOXY-4,4-DIOXY-POLYALKYL-PIPERIDINE COMPOUNDS, WITH GLYCIDYL OR ALKYLCARBONYL GROUPS AS FUNCTIONAL INITIATORS FOR CONTROLLED RADICAL POLYMERIZATION | CIBA SC HOLDING AG (CH) | 2004-06-16 | — | — | EP | disclosed |
| EP-1341763-A2 | N-ALKOXY-4,4-DIOXY-POLYALKYL-PIPERIDINE COMPOUNDS, WITH GLYCIDYL OR ALKYLCARBONYL GROUPS AS FUNCTIONAL INITIATORS FOR CONTROLLED RADICAL POLYMERIZATION | Ciba SC Holding AG (CH) | 2003-09-10 | — | — | EP | disclosed |
| WO-2002048109-A2 | N-ALKOXY-4,4-DIOXY-POLYALKYL-PIPERIDINES AS RADICAL POLYMERIZATION INITIATORS | CIBA SPECIALTY CHEMICLAS HOLDING INC. (CH) | 2002-06-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070173570-A1 | N-alkoxy-4, 4-dioxy-polyalkyl-piperidine compounds, with glycidyl or alkylcarbonyl groups as functional initiators for controlled radical polymerization | PTGER4, ALKBH3, PIGO | TDP1 3387/4885MEN1 4792/4885KMT2A 983/4885 |
| US-20040049043-A1 | N-alkoxy-4,4-dioxy-polyalkyl-piperidine compounds, with glycidyl or alkylcarbonyl groups as functional initiators for controlled radical polymerization | PAOX, ALKBH3, PTGER4 | TDP1 2766/4885MEN1 4857/4885KMT2A 1176/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.